抗生物質耐性を逆転させる多剤進化戦略

Michael Baym¹, Laura K Stone¹, Roy Kishony²

¹Department of Systems Biology, Harvard Medical School, Boston, MA, USA.

Science (New York, N.Y.)

|January 2, 2016

まとめ

抗生物質の組み合わせはバクテリアを殺し同時に耐性菌を選択することができますこのアプローチは抗生物質耐性に対抗するために薬物相互作用を利用し進化を逆転させる可能性があります

科学分野:

微生物学
進化生物学
薬理学について

背景:

抗生物質療法には2つの課題があります細菌の即時の抑制と耐性の長期的発生です
抗生物質耐性の進化は公衆衛生に重大な脅威をもたらしています
現在の戦略では,治療効果と抵抗性の選択を切り離すことはしばしばできません.

研究の目的:

バクテリアの増殖を阻害し耐性を抑制する新しい抗生物質の組み合わせ戦略を探求する.
抗生物質の効能と耐性選択の分離の背後にあるメカニズムを調査する.
抗生物質耐性の進化を制限または逆転させるための潜在的なパラダイムを特定する.

主な方法:

細菌系における薬物相互作用の分析
薬剤相互作用ネットワークに対する耐性変異の影響を調査する.
バクテリア集団の進化動態を組み合わせてモデル化する.

主要な成果:

特定の抗生物質の組み合わせが細菌の増殖を阻害し同時に耐性菌株に対して選択することが示されました
ある薬に対する耐性突然変異が他の薬に対する感受性を高めるメカニズムを特定した.
薬の相互作用を利用することで抵抗性の選択的圧力に対抗することが明らかになった.

結論:

新しい抗生物質の組み合わせ戦略は抗生物質耐性に対抗する有望なアプローチを提供します
耐性リスクから治療の有効性を切り離すことは,慎重に薬物を選択し,耐性変異の影響を理解することによって達成できます.
ゲノム診断の将来的な開発とさらなる検証は,抗生物質耐性を制限または逆転する臨床応用につながる可能性があります.

さらに関連する動画

11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.6K

05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

1.2K

関連する概念動画

01:30

Development of Antibiotic Resistance

1.9K

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

1.9K

01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...

Antibiotic Selection

Combined Effects of Drugs: Synergism

7.4K

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

7.4K

01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...

01:16

Transduction

2.6K

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...